Induction of high incidence of mammary tumour in female Noble rats with a combination of 17β-oestradiol and testosterone

Carcinogenesis

Volumn 20, Issue 6, 1999, Pages 1069-1078

  Xie, B ^a   Tsao, S W ^a   Wong, Y C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; TESTOSTERONE;

ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CARCINOMA IN SITU; CONTROLLED STUDY; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HYPERPLASIA; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR PROMOTION;

ANIMALS; BODY WEIGHT; COCARCINOGENESIS; ESTRADIOL; FEMALE; INCIDENCE; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; TESTOSTERONE;

EID: 0033059603     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.6.1069     Document Type: Article

References (58)

1. Parker, S.L., Tong, T., Bolden, S. and Wingo, P.A. (1997) Cancer statistics 1997. CA Cancer J. Clin., 47, 5-27.
2. Pike, M.C., Krailo, M.D., Henderson, B.E., Casagrande, J.T. and Hoel, D.G. (1983) 'Hormonal' risk factor, 'breast tissue age' and the age-incidence of breast cancer. Nature, 303, 767-770.
3. Bernstein, L. and Ross, R.K. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15, 48-65.
4. Boyle, P. (1988) Epidemiology of breast cancer. Bailliere's Clin. Oncol., 2, 1-8.
5. Dickson, R.B. and Lippman, M.E. (1987) Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrinol. Rev., 8, 29-43.
6. Horwitz, K.B. and McGuire, W.L. (1978) Nuclear mechanism of estrogen action. Effect of esuadiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem., 253, 8185-8191.
7. Rochefort, H. and Garcia, M. (1983) The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol. Ther., 23, 193-216.
8. Kesey, J.L. (1993) Breast cancer epidemiology: summary and future directions. Epidemiol. Rev., 15, 256-263.
9. Berrino, F., Muti, P., Micheli, A., Bolelli, G., Krogh, V., Sciajno, R., Pisani, P., Panico, S. and Secreto, G. (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J. Natl Cancer Inst., 88, 291-296.
10. King, R.J.B. (1991) A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis. J. Steroid Biochem. Mol. Biol., 39, 811-819.
11. Chilers, C,E.D. and Smith, S.J. (1994) The effect of patterns of oral contraceptive use on breast cancer risk in young women. Br. J. Cancer, 67, 922-923.
12. Colditz, G.A., Egan, K.M. and Stampfer, M.J. (1993) Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies. Am. J. Obstet. Gynecol., 168, 1473-1480.
13. Dao, T.L. (1981) The role of ovarian steroid hormones in mammary carcinogenesis. In Pike, M.C., Siiteri, P.K. and Welsch, C.W. (eds) Hormones and Breast Cancer. Banbury Report No. 8. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 281-295.
14. Veronesi, U., Goldhirsch, A. and Yarnold, J. (1995) Breast cancer. In Peckham, M., Pinedo, H. and Veronesi, U. (eds) Oxford Textbook of Oncology. Oxford University Press, New York, NY, pp. 1243-1289.
15. Fentiman, I.S. (1993) The Endocrine Dimension in Prevention of Breast Cancer. RG Landes Company, Austin, TX.
16. Bulbrook, R.D., Hayward, J.L., Wang, D.Y., Thomas, B.S., Clark, G.M., Allen, D.S. and Moore, L.W. (1986) Identification of women with a high risk of breast cancer. Breast Cancer Res. Treat., 7 (suppl.), 5-10.
17. Sereto, G., Toniolo, P., Berrino, F., et al. (1991) Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res., 51, 2572-2576.
18. Veronesi, U. and Pizzocaro, G. (1968) Breast cancer in women subsequent to cystic disease of the breast. Surg. Gynecol. Obstet., 126, 529-532.
19. Secreto, G., Toniolo, P., Berrino, F., Recchione, C., Fariselli, G. and Decarli, A. (1984) Increased androgen activity and breast cancer risk in premenopausal women. Cancer Res., 44, 5902-5905.
20. Dorgan, J.F., Longcope, C., Stephenson, H.E., Falk, R.T., Franz, C., Kahle, L., Campbell, W.S., Tangrea, J.A. and Schatzkin, A. (1997) Serum sex hormone levels are related to breast cancer risk in postmenopausal women. Environ. Health Perspect., 105 (suppl.), 583-585.
21. Dorgan, J.F., Longcope, C., Stephenson, H.E.Jr, et al. (1996) Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 5, 533-539.
22. Thomas, H.V., Key, T.J., Allen, D.S., et al. (1997) A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey. Br. J. Cancer, 76, 401-405.
23. Zeleniuch-Jacquotte, A., Bruning, P.F., Bonfrer, J.M., et al. (1997) Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am. J. Epidemiol., 145, 1030-1038.
24. Secreto, G., Toniolo, P., Berrino, F., et al. (199) Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res., 51, 2572-2576.
25. Adami, H.O., Johansson, E.D., Vegelius, J. and Victor, A. (1979) Serum concentrations of estrone androstenedione, testosterone and sex-hormone binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups. J. Med. Sci., 84, 259-274.
26. Secreto, G., Recchione, C., Cavalleri, A., Miraglia, M. and Dati, V. (1983) Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br. J. Cancer, 47, 269-275.
27. Wysowski, D.K., Comstock, G.W., Helsing, K.J. and Lau, H.L. (1987) Sex hormone levels in serum in relation to the development of breast cancer. Am. J. Epidemiol., 125, 791-799.
28. Garland, C.F., Friedlander, N.J., Barrett-Connor, E. and Khaw, K.T. (1992) Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am. J. Epidemiol., 135, 1220-1230.
29. James, V.H., McNeill, J.M., Lai, L.C, Newton, C.J., Ghilchik, M.W. and Reed, M.J. (1987) Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids, 50, 269-279.
30. Thijssen, J.H., Blankenstein, M.A., Donker, G.H. and Daroszewski, J. (1991) Endogenous steroid hormones and local aromatase activity in the breast. J. Steroid Biochem. Mol. Biol., 39, 799-804.
31. Zhang, R., Haag, J.D. and Gould, M.N. (1990) Reduction in the frequency of activated ras oncogenes in rat mammary carcinoma with increasing N-melhyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res., 50, 4286-4290.
32. Noble, R.L. (1976) A new characteristic transplantable type of breast carcinoma in Nb rats following combined estrogen-androgen treatment, Proc. Am. Assoc. Cancer Res., 17, 221.
33. Key, T.J.A. (1995) Hormones and cancer in humans. Mutat. Res., 333, 59-67.
34. Xie, B., Tsao, S.W. and Wong, Y.C. (1997) Expression of transforming growth factor symbol β1 and its receptors in the development of breast cancer in the Noble (Nb) rat. Proceedings of 14th International Symposium on Morphological Sciences, p. 471.
35. Xie, B., Tsao, S.W. and Wong, Y.C. (1998) Expression of vascular endothelial growth factor (VEGF) and its receptors in the development of breast cancer in the Noble (Nb) rat. Proc. Am. Assoc. Cancer Res., 39, 375.
36. Xie, B., Tsao, S.W. and Wong, Y.C. Induction breast cancer in female Noble rats treated with a combination of testosterone and estradiol-17β. Proceedings of 11th Asia-Oceania Congress of Endocrinology, p. 143.
37. Young, S. and Hallowes, R.C. (1976) Tumors of the mammary gland. In Turusov, V.S. (ed.) Pathology of Tumors in Laboratory Animals, Vol. 1. IARC Scientific Publications No. 17, IARC, Lyon, pp. 31-74.
38. Russo, J., Russo, I.H., Rogers, A.E., Van Zwietan, M.J. and Gusterson, B. (1990) Tumors of the mammary gland. IARC Scientific Publications No. 99, IARC, Lyon, pp. 47-78.
39. Iball, J. (1939) The relative potency of carcinogenic compounds. Am. J. Cancer, 35, 188-190.
40. SPSS Inc. (1996) SPSS Base 7.0 for Windows User's Guide. SPSS Inc., Chicago, IL.
41. Dao, T.L. (1962) The role of ovarian hormones initiating the induction of mammary cancer in rats by polynuclear hydrocarbons. Cancer Res., 22, 973-980.
42. Huggins, C., Grand, L.C. and Brillantes, F.P. (1959) Critical significance of breast structure in the induction of mammary cancer in the rat. Proc. Natl Acad. Sci. USA, 45, 1294-1300.
43. Russo, I.H. and Russo, J. (1978) Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz(a)anthracene. J. Natl Cancer Inst., 61, 1439-1442.
44. McCormick, D.L., Adamowski, C.B., Fiks, A and Moon, R.C. (1981) Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res., 41, 2690-2695.
45. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
46. Harris, M., Howell, A., Chrissohou, M., Swindell, R.I.C., Hudson, M. and Sellwood, R.A. (1984) A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of breast. Br. J. Cancer, 50, 23-30.
47. Liehr, J.G. (1997) Hormone-associated cancer: Mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ. Health Perspect., 105 (suppl.), 565-569.
48. Ziegler, R.G., Rossi, S.C., Fears, T.R. et al. (1997) Quantifying estrogen metabolism: An evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16α-hydroxyestrone in urine. Environ. Health Perspect., 105 (suppl.), 607-614.
49. Davis, D.L., Telang, N.T., Osborne, M.P. et al. (1997) Medical hypothesis: Bifunctional genetic-hormonal pathways to breast cancer. Environ. Health Perspect., 105 (suppl.), 571-576.
50. Telang, N.T., Katdare, M., Bradlow, H.L. et al. (1997) Estradiol metabolism: An endocrine biomarker for modulation of human mammary carcinogenesis. Environ. Health Perspect., 105 (suppl.), 559-564.
51. Davis, D.L. and Sieber, S.M. (1997) Hormones, hormone metabolism, environment and breast cancer: A workshop of the national action plan on breast cancer's etiology working group. Environ. Health Perspect., 105 (suppl.), 557.
52. Secreto, G. and Zumoff, B. (1994) Abnormal production of androgens in women with breast cancer. Anticancer Res., 14, 2113-2117.
53. Henderson, B.E., Ross, R.K. and Pike, M.C. (1993) Hormonal chemoprevention of cancer in women. Science, 259, 633-638.
54. Siiteri, P.K., Hammond, G.L. and Nisker, J.A. (1981) Increased availability of serum estrogens in breast cancer: a new hypothesis. In Pike, M.C., Siiteri, P.K. and Welsch C.W. (eds) Hormones and Breast Cancer. Banbury Report No 8. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 87-101.
55. Lonning, P.E., Helle, S.I., Johannessen, D.C. et al. (1995) Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor binding protein-1 in postmenopausal breast cancer patients. Clin. Endocrinol., 42, 23-30.
56. Russo, J. and Russo, I.H. (1978) DNA-labeling index and structure of the rat mammary gland as determinant of its susceptibility to carcinogenesis. J. Natl Cancer Inst., 61, 1451-1459.
57. Russo, J., Wilgus, G. and Russo, I.H. (1979) Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am. J. Pathol., 96, 721-734.
58. Russo, J., Saby, J., Isenberg, W. and Russo, I.H. (1997) Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz(a)anthracene. J. Natl Cancer Inst., 59, 435-445.